Yeast Infection Treatment Global Market Report 2025
상품코드:1695326
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
효모감염증 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 5.9%의 성장률로 58억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 원격진료를 위한 원격의료 도입 증가, 표적 치료를 위한 맞춤형 의료 접근법, 효과 향상을 위한 병용요법의 출현, 자연 요법 및 약초 요법에 대한 관심 증가, 감염 관리를 위한 미생물 기반 치료에 대한 관심 증가 등에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 유전체 연구의 발전, 소형의 정확한 진단 기기 개발, 효모 감염 진단 및 치료 분야의 기술 발전, 연구개발 투자 증가, 전략적 파트너십 등을 꼽을 수 있습니다.
자가면역질환 유병률의 증가는 당분간 효모감염증 치료 시장의 성장을 견인할 것으로 예상됩니다. 자가면역질환은 면역체계가 건강한 세포, 조직, 장기를 잘못 공격하여 신체 기능 저하 및 생명을 위협하는 합병증을 유발할 수 있습니다. 효모감염증 치료는 특정 자가면역 증후군과 관련된 재발성 효모 감염에 대처함으로써 자가면역 질환의 합병증을 관리하고 예방하는 데 중요한 역할을 합니다. 또한, 자가면역질환 환자의 진균 감염을 관리함으로써 면역반응을 조절할 수 있는 가능성도 있습니다. 예를 들어, 2023년 3월 현재 미국 국립보건원(National Institutes of Health)은 2021년 전 세계 1형 당뇨병(T1DM) 환자 수는 840만 명으로 추산되며, 그 해에 50만 명의 신규 환자가 보고되었다고 보고했습니다. 예측에 따르면, 2040년까지 T1DM 인구는 1,350만 명에서 1,740만 명에 달할 것으로 보입니다. 따라서 자가면역질환의 유병률 증가는 효모감염증 치료 시장의 성장을 촉진하고 있습니다.
효모감염증 치료 시장의 주요 기업들은 경쟁력을 강화하기 위해 비아졸계 경구용 항진균제와 같은 혁신적인 솔루션을 도입하는 데 주력하고 있습니다. 비아졸계 경구용 항진균제는 아졸계에 속하지 않고 곰팡이 감염에 대응하도록 설계된 약물입니다. 예를 들어, 미국 생명공학 기업 사이넥시스(SCYNEXIS)는 2022년 12월 미국 식품의약국(FDA)으로부터 두 번째 적응증인 BREXAFEMME(이브 렉사 팡가프 정)의 승인을 받았습니다. 광범위한 효능으로 재발성 외음부 칸디다증 환자의 제한된 치료 옵션에 대한 새로운 치료 옵션을 제공함으로써 시장 판도를 재편할 수 있을 것으로 기대됩니다. 브렉사펨메의 VVC 치료 권장 용량은 300mg(150mg×2정) 1일 1회, 총 600mg(150mg×4정)을 1일 1회 복용합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 효모감염증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 효모감염증 치료 시장 : 성장률 분석
세계의 효모감염증 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 효모감염증 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 효모감염증 치료 전체 시장(TAM)
제6장 시장 세분화
세계의 효모감염증 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
분말
크림 또는 연고
정제 또는 캡슐
기타 유형
세계의 효모감염증 치료 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
치료
수술
세계의 효모감염증 치료 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
성기 칸디다증
침습성 칸디다증
구강인두 또는 식도 칸디다증(칸디다증)
기타 적응증
세계의 효모감염증 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
국소
IV(정맥내) 또는 IM(근육내)
기타 투여 경로
세계의 효모감염증 치료 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소매 약국 또는 드럭스토어
병원 약국
전문점
온라인 판매
기타 용도
세계의 효모감염증 치료 시장, 분말 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
항진균 파우더
약용 바디 파우더
세계의 효모감염증 치료 시장, 크림 또는 연고 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
항진균 크림
질연고
외용 크림
세계의 효모감염증 치료 시장, 정제 또는 캡슐제 종류별 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 항진균 자물쇠
프로바이오틱스 캡슐
질정
세계의 효모감염증 치료 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
좌약
스프레이
젤
제7장 지역별·국가별 분석
세계의 효모감염증 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 효모감염증 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
효모감염증 치료 시장 : 경쟁 구도
효모감염증 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Thermo Fisher Scientific Inc.
Abbott Laboratories
AstraZeneca PLC
Bayer AG
Astellas Pharma Inc.
Torrent Pharmaceuticals
Catalent Inc.
bioMerieux SA
Cipla
Bruker Corporation
Brundavan Laboratories Private Limited
Glenmark Pharmaceuticals Ltd
Zydus Lifesciences
Prestige Consumer Healthcare Inc.
CordenPharma International
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
효모감염증 치료 시장 2029 : 새로운 기회를 제공하는 국가
효모감염증 치료 시장 2029 : 새로운 기회를 제공하는 부문
효모감염증 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Yeast infection treatment refers to medications utilized to address infections resulting from Candida fungus overgrowth, commonly known as yeast infections or candidiasis. These infections can manifest in various body parts such as the mouth (oral thrush), genitals (vaginal yeast infection), skin, and mucous membranes. The treatments aim to alleviate yeast infection symptoms.
Yeast infection treatment come in different forms such as powders, creams, ointments, tablets, or capsules, and can involve medical treatment or surgery. Indications for these treatments include genital candidiasis, invasive candidiasis, oropharyngeal or esophageal candidiasis (thrush), among others. Administration routes include oral, topical, IV (intravenous), or IM (intramuscular), and the treatments are utilized across various applications such as retail pharmacies, hospital pharmacies, specialty stores, online sales, and more.
The yeast infection treatment market research report is one of a series of new reports from The Business Research Company that provides yeast infection treatment market statistics, including yeast infection treatment industry global market size, regional shares, competitors with a yeast infection treatment market share, detailed yeast infection treatment market segments, market trends and opportunities, and any further data you may need to thrive in the yeast infection treatment industry. This yeast infection treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The yeast infection treatment market size has grown strongly in recent years. It will grow from $4.33 billion in 2024 to $4.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased prevalence of yeast infections, growing awareness about fungal infections, aging population, rise in healthcare expenditure globally, and development and approval of new antifungal medications.
The yeast infection treatment market size is expected to see strong growth in the next few years. It will grow to $5.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of telemedicine for remote consultations, personalized medicine approaches for targeted treatment, emergence of combination therapies for enhanced efficacy, growing emphasis on natural and herbal remedies, and focus on microbiome-based therapies for infection management. Major trends in the forecast period include advancements in genomic research, development of compact and accurate diagnostic equipment, technological advancements in the field of yeast infection diagnosis and treatment, increasing investments in research and development, and strategic partnerships.
The anticipated increase in autoimmune disease prevalence is forecasted to drive the expansion of the yeast infection treatment market in the foreseeable future. Autoimmune diseases involve the immune system mistakenly attacking healthy cells, tissues, and organs, leading to weakened bodily functions and potentially life-threatening complications. Yeast infection treatments play a crucial role in managing and preventing autoimmune disease complications by addressing recurrent yeast infections associated with certain autoimmune syndromes. Additionally, they may modulate the immune response by managing fungal infections in patients with autoimmune conditions. For instance, as of March 2023, the National Institutes of Health reported an estimated 8.4 million global cases of type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported that year. Projections indicate the T1DM population to reach between 13.5 and 17.4 million by 2040. Hence, the increasing prevalence of autoimmune diseases is fostering the growth of the yeast infection treatment market.
Key players in the yeast infection treatment market are concentrating on introducing innovative solutions, such as non-azole oral antifungals, to enhance their competitive position. A non-azole oral antifungal is a medication designed to combat fungal infections without belonging to the azole class. For instance, in December 2022, SCYNEXIS, a US-based biotechnology company, received approval from the United States Food and Drug Administration (FDA) for BREXAFEMME (ibrexafungerp tablets), marking its second indication. BREXAFEMME is a pioneering non-azole oral antifungal, the first FDA-endorsed therapy for treating vaginal yeast infections (vulvovaginal candidiasis, VVC) and reducing the recurrence of VVC. With its broad-spectrum activity, BREXAFEMME provides a novel alternative, addressing the limited treatment options for patients with recurrent VVC and reshaping the yeast infection treatment market landscape. The recommended dosage of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets) administered one day apart, totaling 600 mg (four 150 mg tablets) daily.
In March 2023, GlaxoSmithKline Plc, a UK-based biopharma company, entered into a partnership with Scynexis to advance the development of Brexafemme (isavuconazonium sulfate) for treating vaginal yeast infections. Through this collaboration, the availability and accessibility of this innovative treatment are expected to be significantly enhanced, providing substantial benefits for patients with challenging infections caused by resistant fungi. Scynexis, a US-based biotechnology company, specializes in creating innovative therapies for hard-to-treat infections, with a primary focus on fungal infections.
Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMerieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP
North America was the largest region in the yeast infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the yeast infection treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The yeast infection treatment market consists of revenues earned by entities by providing diagnostic testing, personalized treatment plans, telemedicine consultations, educational programs and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The yeast infection treatment market also includes sales of miconazole, terconazole, fluconazole, amphotericin B, itraconazole, and caspofungin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Yeast Infection Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on yeast infection treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for yeast infection treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yeast infection treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Powders; Creams Or Ointments; Tablets Or Capsules; Other Types
2) By Treatment: Medical Treatment; Surgery
3) By Indication: Genital Candidiasis; Invasive Candidiasis; Oropharyngeal Or Esophageal Candidiasis (Thrush); Other Indications
4) By Route Of Administration: Oral; Topical; IV (Intravenous) Or IM (Intramuscular); Other Routes Of Administration
5) By Application: Retail Pharmacies Or Drug Stores; Hospital Pharmacies; Specialty Stores; Online Sales; Other Applications
Subsegments:
1) By Powders: Antifungal Powders; Medicated Body Powders
2) By Creams Or Ointments: Antifungal Creams; Vaginal Ointments; Topical Creams
3) By Tablets Or Capsules: Oral Antifungal Tablets; Probiotic Capsules; Vaginal Tablets
4) By Other Types: Suppositories; Sprays; Gels
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis International AG; Sanofi SA
3. Yeast Infection Treatment Market Trends And Strategies
4. Yeast Infection Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Yeast Infection Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Yeast Infection Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Yeast Infection Treatment Market Growth Rate Analysis
5.4. Global Yeast Infection Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Yeast Infection Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Yeast Infection Treatment Total Addressable Market (TAM)
6. Yeast Infection Treatment Market Segmentation
6.1. Global Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powders
Creams Or Ointments
Tablets Or Capsules
Other Types
6.2. Global Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Treatment
Surgery
6.3. Global Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genital Candidiasis
Invasive Candidiasis
Oropharyngeal Or Esophageal Candidiasis (Thrush)
Other Indications
6.4. Global Yeast Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
IV (Intravenous) Or IM (Intramuscular)
Other Routes Of Administration
6.5. Global Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies Or Drug Stores
Hospital Pharmacies
Specialty Stores
Online Sales
Other Applications
6.6. Global Yeast Infection Treatment Market, Sub-Segmentation Of Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Powders
Medicated Body Powders
6.7. Global Yeast Infection Treatment Market, Sub-Segmentation Of Creams Or Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Creams
Vaginal Ointments
Topical Creams
6.8. Global Yeast Infection Treatment Market, Sub-Segmentation Of Tablets Or Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Antifungal Tablets
Probiotic Capsules
Vaginal Tablets
6.9. Global Yeast Infection Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Suppositories
Sprays
Gels
7. Yeast Infection Treatment Market Regional And Country Analysis
7.1. Global Yeast Infection Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Yeast Infection Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
